SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

North Anna power plant seeks ESP renewal

August 6, 2026, 12:32PMNuclear News

Dominion Energy Virginia is seeking a 20-year renewal of the early site permit (ESP) the Nuclear Regulatory Commission issued for its North Anna nuclear power plant site in Virginia. North...